Affiliations: [a] Laboratory of Neurochemistry, Neurology Department, Coimbra University Hospital, Coimbra, Portugal | [b] Neurology Department, Coimbra University Hospital, Coimbra, Portugal | [c] Center for Neuroscience and Cell Biology, Faculty of Medicine, University of Coimbra, Coimbra, Portugal
Correspondence:
[*]
Corresponding author: Inês Baldeiras, Laboratory of Neurochemistry, Neurology Department, Hospitais da Universidade de Coimbra, Praceta Mota Pinto, 3000 Coimbra, Portugal. Tel.: 351 239 400448; Fax: 351 239 822637; E-mail: ines.baldeiras@sapo.pt.
Abstract: Oxidative stress has been shown to be a triggering event in the pathogenesis of Alzheimer's disease (AD). However, little evidence exists on the role of oxidative imbalance in Mild Cognitive Impairment (MCI), a group with a high risk of progression to AD. We therefore assessed the peripheral blood levels of a broad spectrum of non-enzymatic and enzymatic antioxidant defenses, as well as lipid and protein oxidation markers and nitrogen oxidative species in 85 MCI patients, 42 mild AD patients and 37 age-matched controls. In mild AD patients, the plasma levels of vitamin E were significantly decreased, while the plasma concentration of oxidized glutathione was increased in both MCI and mild AD patients. An increase in plasmatic and erythrocytes oxidative markers was also observed in MCI and mild AD patients as compared to controls. In both patients groups, increased levels of plasma antioxidants were found in females, whereas apolipoprotein E ε4 allele carriers showed higher indices of intracellular oxidative markers. Moreover, in MCI patients, cognitive function positively correlates with antioxidant levels. This study shows that most of the oxidative changes found in mild AD patients are already present in the MCI group, and that progression to AD might be accompanied by antioxidant depletion.
